100% Original
Niedrigster Preis
Kostenloser Versand

Amaryl 4mg 30 Tablets

EGP108

5 Produkte wurden in den letzten 18 Stunden verkauft
Verkauft sich schnell! Über 5 Personen haben in ihrem Warenkorb
28 Personen sehen sich das gerade an
  • Check Mark Estimated Delivery : Same day
  • Check Mark Free Shipping & Returns : On all orders over 200 EGP
  • Visa Card
  • MasterCard
  • American Express
  • Discover Card
  • PayPal
  • Apple Pay
Guaranteed Safe And Secure Checkout

Medication Name: Amaryl 4mg 30 Tablets

Active Ingredient:
Glimepiride 4mg

Pharmacological Class:
Sulfonylurea antidiabetic agent

Indications:
Used to improve glycemic control in adults with type 2 diabetes mellitus when diet and exercise alone are not sufficient. It may be used as monotherapy or in combination with other antidiabetic medications such as metformin, pioglitazone, or insulin.

Mechanism of Action:
Stimulates the release of insulin from pancreatic beta cells and enhances the sensitivity of peripheral tissues to insulin, thereby lowering blood glucose levels.

Dosage:

  • Typical starting dose: 1mg once daily with breakfast or the first main meal.

  • Maintenance dose: Adjust gradually based on blood glucose response.

  • Maximum recommended dose: 8mg once daily.

  • Take with or immediately after food to reduce the risk of hypoglycemia.

Precautions:

  • Monitor blood glucose regularly to detect hypoglycemia.

  • Use cautiously in patients with renal or hepatic impairment.

  • Avoid skipping meals or prolonged fasting.

  • Not recommended for type 1 diabetes or diabetic ketoacidosis.

  • Stop treatment temporarily before major surgery or severe illness.

Possible Side Effects:

  • Hypoglycemia (sweating, tremor, dizziness, hunger)

  • Nausea or stomach discomfort

  • Headache

  • Mild weight gain

  • Rare: allergic skin reactions, liver enzyme elevation, or visual disturbances

Bewertungen

Es gibt noch keine Bewertungen.

Seien Sie die erste Kundenmeinung "Amaryl 4mg 30 Tablets"

Deine E-Mail-Adresse wird nicht veröffentlicht. Erforderliche Felder sind mit * markiert